Correlation Between CRISPR Therapeutics and Computershare

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CRISPR Therapeutics and Computershare at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CRISPR Therapeutics and Computershare into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CRISPR Therapeutics AG and Computershare Limited, you can compare the effects of market volatilities on CRISPR Therapeutics and Computershare and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CRISPR Therapeutics with a short position of Computershare. Check out your portfolio center. Please also check ongoing floating volatility patterns of CRISPR Therapeutics and Computershare.

Diversification Opportunities for CRISPR Therapeutics and Computershare

-0.33
  Correlation Coefficient

Very good diversification

The 3 months correlation between CRISPR and Computershare is -0.33. Overlapping area represents the amount of risk that can be diversified away by holding CRISPR Therapeutics AG and Computershare Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Computershare Limited and CRISPR Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CRISPR Therapeutics AG are associated (or correlated) with Computershare. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Computershare Limited has no effect on the direction of CRISPR Therapeutics i.e., CRISPR Therapeutics and Computershare go up and down completely randomly.

Pair Corralation between CRISPR Therapeutics and Computershare

Assuming the 90 days trading horizon CRISPR Therapeutics AG is expected to generate 2.86 times more return on investment than Computershare. However, CRISPR Therapeutics is 2.86 times more volatile than Computershare Limited. It trades about 0.13 of its potential returns per unit of risk. Computershare Limited is currently generating about 0.1 per unit of risk. If you would invest  4,080  in CRISPR Therapeutics AG on April 22, 2025 and sell it today you would earn a total of  1,470  from holding CRISPR Therapeutics AG or generate 36.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

CRISPR Therapeutics AG  vs.  Computershare Limited

 Performance 
       Timeline  
CRISPR Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CRISPR Therapeutics AG are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively fragile basic indicators, CRISPR Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Computershare Limited 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Computershare Limited are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, Computershare may actually be approaching a critical reversion point that can send shares even higher in August 2025.

CRISPR Therapeutics and Computershare Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CRISPR Therapeutics and Computershare

The main advantage of trading using opposite CRISPR Therapeutics and Computershare positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CRISPR Therapeutics position performs unexpectedly, Computershare can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Computershare will offset losses from the drop in Computershare's long position.
The idea behind CRISPR Therapeutics AG and Computershare Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets